341 related articles for article (PubMed ID: 34895230)
1. Emerging role of m6A methylation modification in ovarian cancer.
Chang LL; Xu XQ; Liu XL; Guo QQ; Fan YN; He BX; Zhang WZ
Cancer Cell Int; 2021 Dec; 21(1):663. PubMed ID: 34895230
[TBL] [Abstract][Full Text] [Related]
2. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer.
Zhang Y; Ling Y; Zhou Y; Shi X; Shen F; Zhou J; Chen Y; Yang F; Gu Y; Wang J
Cancer Control; 2024; 31():10732748241256819. PubMed ID: 38755968
[TBL] [Abstract][Full Text] [Related]
3. RNA m6A methylation regulators in ovarian cancer.
Guo J; Zheng J; Zhang H; Tong J
Cancer Cell Int; 2021 Nov; 21(1):609. PubMed ID: 34794452
[TBL] [Abstract][Full Text] [Related]
4. A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer.
Li Q; Ren CC; Chen YN; Yang L; Zhang F; Wang BJ; Zhu YH; Li FY; Yang J; Zhang ZA
Front Cell Dev Biol; 2021; 9():703969. PubMed ID: 34631700
[TBL] [Abstract][Full Text] [Related]
5. Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours.
Xia Z; Kong F; Wang K; Zhang X
Front Pharmacol; 2022; 13():908079. PubMed ID: 35754499
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
[TBL] [Abstract][Full Text] [Related]
7. Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer.
Luo Y; Sun X; Xiong J
Front Cell Dev Biol; 2021; 9():794801. PubMed ID: 35087835
[No Abstract] [Full Text] [Related]
8. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
Front Oncol; 2022; 12():927640. PubMed ID: 35936737
[TBL] [Abstract][Full Text] [Related]
10. Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
Gu J; Bi F
Front Genet; 2021; 12():671179. PubMed ID: 34306015
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
Zheng J; Guo J; Cao B; Zhou Y; Tong J
Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of m6A RNA modification in cancer therapeutic resistance.
Liu WW; Zhang ZY; Wang F; Wang H
Exp Hematol Oncol; 2023 Feb; 12(1):21. PubMed ID: 36810281
[TBL] [Abstract][Full Text] [Related]
13. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
[TBL] [Abstract][Full Text] [Related]
14. The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development.
Liu S; Chen S; Tang C; Zhao Y; Cui W; Jia L; Wang L
Front Oncol; 2022; 12():970833. PubMed ID: 36226062
[TBL] [Abstract][Full Text] [Related]
15. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
Fang X; Li M; Yu T; Liu G; Wang J
Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
[TBL] [Abstract][Full Text] [Related]
16. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
Chen M; Wong CM
Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
[TBL] [Abstract][Full Text] [Related]
17. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis.
Zhang X; Zhang S; Yan X; Shan Y; Liu L; Zhou J; Kuang Q; Li M; Long H; Lai W
J Cell Mol Med; 2021 Apr; 25(7):3634-3645. PubMed ID: 33724691
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining.
Zeng J; Zhang H; Tan Y; Wang Z; Li Y; Yang X
J Transl Med; 2021 Jul; 19(1):323. PubMed ID: 34330301
[TBL] [Abstract][Full Text] [Related]
19. The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.
Cai T; Atteh LL; Zhang X; Huang C; Bai M; Ma H; Zhang C; Fu W; Gao L; Lin Y; Meng W
Front Surg; 2022; 9():819335. PubMed ID: 35155557
[TBL] [Abstract][Full Text] [Related]
20. The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer.
Xu X; Zhao J; Yang M; Han L; Yuan X; Chi W; Jiang J
Eur J Med Res; 2023 Nov; 28(1):475. PubMed ID: 37915103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
